サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1391066

がん腫瘍プロファイリングの世界市場レポート 2024年

Cancer Tumor Profiling Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
がん腫瘍プロファイリングの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

世界のがん患者の急増は、がん腫瘍プロファイリング市場の成長を促進すると予想されます。制御不能な細胞増殖と拡散を特徴とするがんは、疾患の重症度を評価するためにがん腫瘍プロファイリングのような高度な診断ツールを必要とします。2021年、米国がん協会は、2020年に新たに診断されたがんの症例が180万件に上ると報告し、世界的にがんの有病率が増加していることを強調しています。がん罹患率の増加は、がん腫瘍プロファイリング市場の拡大に大きく寄与しています。

北米は、2023年のがん腫瘍プロファイリング市場において最大の地域でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。がん腫瘍プロファイリング市場レポートがカバーする地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 がん腫瘍プロファイリング市場の特徴

第3章 がん腫瘍プロファイリング市場の動向と戦略

第4章 がん腫瘍プロファイリング市場-マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界のがん腫瘍プロファイリング市場規模と成長

  • 世界のがん腫瘍プロファイリング市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のがん腫瘍プロファイリングの市場規模実績と成長、2018～2023年
  • 世界のがん腫瘍プロファイリング市場規模と成長予測、2023～2028年、2033年

第6章 がん腫瘍プロファイリング市場セグメンテーション

  • 世界のがん腫瘍プロファイリング市場、がんのタイプ別セグメンテーション、実績および予測、2018～2023年、2023～2028年、2033年
  • 肺がん
  • 乳がん
  • 結腸直腸がん
  • 前立腺がん
  • 黒色腫
  • 卵巣がん
  • 胃がん
  • 膵臓がん
  • 甲状腺がん
  • 他の種類のがん
  • 世界のがん腫瘍プロファイリング市場、技術別セグメンテーション、実績および予測、2018～2023年、2023～2028年、2033年
  • 次世代シーケンス（NGS）
  • ポリメラーゼ連鎖反応（PCR）
  • 免疫組織化学（IHC）
  • in situハイブリダイゼーション（ISH）
  • マイクロアレイ
  • その他の技術
  • 世界のがん腫瘍プロファイリング市場、用途別セグメンテーション、実績および予測、2018～2023年、2023～2028年、2033年
  • 個別化医療
  • 診断
  • バイオマーカーの発見
  • 予後
  • 研究用途

第7章 がん腫瘍プロファイリング市場の地域および国分析

  • 世界のがん腫瘍プロファイリング市場、地域別、実績および予測、2018～2023年、2023～2028年、2033年
  • 世界のがん腫瘍プロファイリング市場、国別、実績および予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋のがん腫瘍プロファイリング市場

第9章 中国のがん腫瘍プロファイリング市場

第10章 インドのがん腫瘍プロファイリング市場

第11章 日本のがん腫瘍プロファイリング市場

第12章 オーストラリアのがん腫瘍プロファイリング市場

第13章 インドネシアのがん腫瘍プロファイリング市場

第14章 韓国のがん腫瘍プロファイリング市場

第15章 西欧のがん腫瘍プロファイリング市場

第16章 英国のがん腫瘍プロファイリング市場

第17章 ドイツのがん腫瘍プロファイリング市場

第18章 フランスのがん腫瘍プロファイリング市場

第19章 イタリアのがん腫瘍プロファイリング市場

第20章 スペインのがん腫瘍プロファイリング市場

第21章 東欧のがん腫瘍プロファイリング市場

第22章 ロシアのがん腫瘍プロファイリング市場

第23章 北米のがん腫瘍プロファイリング市場

第24章 米国のがん腫瘍プロファイリング市場

第25章 カナダのがん腫瘍プロファイリング市場

第26章 南米のがん腫瘍プロファイリング市場

第27章 ブラジルのがん腫瘍プロファイリング市場

第28章 中東のがん腫瘍プロファイリング市場

第29章 アフリカのがん腫瘍プロファイリング市場

第30章 がん腫瘍プロファイリング市場の競合情勢と企業プロファイル

  • がん腫瘍プロファイリング市場の競合情勢
  • がん腫瘍プロファイリング市場の企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Caris Life Sciences
    • Thermo Fisher Scientific Inc.
    • Illumina Inc.
    • Qiagen

第31章 世界のがん腫瘍プロファイリング市場の競合ベンチマーキング

第32章 世界のがん腫瘍プロファイリング市場の競合ダッシュボード

第33章 がん腫瘍プロファイリング市場における主要な合併と買収

第34章 がん腫瘍プロファイリング市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r9426

“Cancer Tumor Profiling Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer tumor profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer tumor profiling? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The cancer tumor profiling market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Cancer Type: Lung Cancer; Breast Cancer; Colorectal Cancer; Prostate Cancer; Melanoma; Ovarian Cancer; Stomach Cancer; Pancreatic Cancer; Thyroid Cancer; Other Cancer Types
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Immunohistochemistry (IHC); In Situ Hybridization (ISH); Microarray; Other Technologies
  • 3) By Process Type: Genomics; Proteomics; Epigenetics; Metabolomics; Other Types
  • 4) By Application: Personalized Medicine; Diagnostics; Biomarker Discovery; Prognostics; Research Applications
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Caris Life Sciences; Thermo Fisher Scientific Inc.; Illumina Inc.; Qiagen
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Cancer tumor profiling is a laboratory testing method designed to analyze a sample of tumor tissue for specific genes, gene mutations, proteins, or other biomarkers. This comprehensive examination aids in treatment planning and provides valuable insights into the likelihood of cancer recurrence or metastasis.

The primary categories of cancer and tumor profiling encompass lung cancer, breast cancer, colorectal cancer, prostate cancer, melanoma, ovarian cancer, stomach cancer, pancreatic cancer, thyroid cancer, and various other cancer types. Diverse technologies, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH), microarrays, and others, are employed in this process. These technologies cover multiple facets, including genomics, proteomics, epigenetics, metabolomics, and more. Cancer and tumor profiling find applications in personalized medicine, diagnostics, biomarker discovery, prognostics, and research endeavors.

The cancer tumor profiling market research report is one of a series of new reports from The Business Research Company that provides cancer tumor profiling market statistics, including cancer tumor profiling industry global market size, regional shares, competitors with a cancer tumor profiling market share, detailed cancer tumor profiling market segments, market trends and opportunities, and any further data you may need to thrive in the cancer tumor profiling industry. This cancer tumor profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer tumor profiling market size has grown rapidly in recent years. It will grow from $11.17 billion in 2023 to $12.93 billion in 2024 at a compound annual growth rate (CAGR) of 15.7%. The historical growth in cancer tumor profiling can be attributed to factors such as the rising incidence of cancer, the expansion of precision medicine initiatives and collaborative research efforts, advancements in cancer diagnostics and early detection methodologies, the availability of a diverse array of targeted therapy options, and supportive regulatory frameworks facilitating cancer profiling tests.

The cancer tumor profiling market size is expected to see rapid growth in the next few years. It will grow to $22.06 billion in 2028 at a compound annual growth rate (CAGR) of 14.3%. The forecasted growth in cancer tumor profiling is anticipated due to the expanding applications of immunotherapy and immunoprofiling in cancer treatment, the development of liquid biopsy and non-invasive tumor profiling methods, the adoption of single-cell sequencing for more detailed tumor characterization, the extension of cancer screening and early detection programs, and the increasing demand for profiling rare and orphan cancer subtypes. Noteworthy trends in the forecast period include the integration of tumor profiling into routine clinical practice, advancements in multi-omics approaches, the incorporation of artificial intelligence (AI) and machine learning in data analysis, the development of personalized medicine and targeted therapy, and progress in genomics and next-generation sequencing (NGS) technologies.

The surge in cancer cases worldwide is expected to drive the growth of the cancer and tumor profiling market. Cancer, characterized by uncontrolled cell growth and spreading, necessitates advanced diagnostic tools such as cancer tumor profiling to assess the severity of the disease. In 2021, the American Cancer Society reported 1.8 million new cancer cases diagnosed in 2020, underscoring the increasing prevalence of cancer globally. The rising incidences of cancer contribute significantly to the expansion of the cancer and tumor profiling market.

The increasing prevalence of stomach cancer is anticipated to be a key driver for the growth of the cancer and tumor profiling market. Stomach cancer involves the uncontrolled growth of malignant cells in the stomach lining, and cancer and tumor profiling play a crucial role in providing insights into the development of this disease. For example, gastrointestinal stromal tumors (GISTs), though distinct from stomach cancer, can occur in the stomach, and cancer and tumor profiling can help in understanding and treating such cases. As indicated by Cancer Research UK, the incidence of stomach cancer in the UK is expected to decline by 12% between 2023-2025 and 2038-2040. This decline, while positive, highlights the need for continued focus on stomach cancer research and tumor profiling to further address the disease. The growing prevalence of stomach cancer is thus contributing to the expansion of the cancer and tumor profiling market.

Increasing research and development activities are emerging as a significant trend in the cancer and tumor profiling market. Major companies in this sector are prioritizing research and development to meet consumer demands and strengthen their market position. For instance, QIAGEN N.V, a German company specializing in sample and assay technology, recently announced the Conformite Europeenne (CE)-marking and commercialization of the therascreen PIK3CA RGQ PCR Kit in Europe. This diagnostic assay is designed to identify breast cancer patients with PIK3CA mutations, providing crucial information for personalized treatment. The emphasis on research and development activities is a notable trend that is shaping the cancer and tumor profiling market.

In June 2023, Quest Diagnostics, a prominent US-based medical laboratory company, completed the acquisition of Haystack Oncology Inc. for a substantial sum of $450 million. The strategic move by Quest Diagnostics is aimed at broadening access to liquid biopsy technology and strengthening its position in the competitive field of cancer diagnostics. This acquisition is anticipated to augment Quest Diagnostics' research and development capabilities, thereby enhancing its ability to contribute to improved outcomes for cancer patients. Haystack Oncology Inc., based in the United States, is an early-stage oncology company specializing in the development of solid tumor testing technology.

In July 2021, Labcorp, another major US-based clinical laboratory, successfully acquired OmniSeq for an undisclosed amount. This strategic acquisition provides Labcorp with an expanded portfolio of clinical trial options and diagnostic tests tailored for cancer patients and healthcare providers. OmniSeq, a US-based company with expertise in solid tumor profiling, possesses innovative sequencing technologies and actively supports drug development through its pharmaceutical services. This acquisition positions Labcorp to play a more significant role in advancing cancer diagnostics and contributing to the ongoing development of therapeutic solutions.

Major companies operating in the cancer tumor profiling market include F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. Ltd., Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc., Agilent Technologies Inc., Myriad Genetics Inc., Personal Genome Diagnostics Inc., Tempus Labs Inc., ArcherDX Inc., Natera Inc., Bio-Rad Laboratories Inc., Genetron Health, NantHealth Inc., Resolution Bioscience, Genomic Testing Cooperative, OncoDNA, Strata Oncology Inc., Genuity Science, RareCyte Inc., Inivata Limited, Cepheid

North America was the largest region in cancer and tumor profiling market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cancer and tumor profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the cancer tumor profiling market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The cancer tumor profiling market includes revenues earned by entities by sanger sequencing, pyro sequencing (PyroSeq), chromogenic/ fluorescence in situ hybridization (CISH/FISH) and fragment analysis (FA/Frag. Analysis). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Cancer Tumor Profiling Market Characteristics

3. Cancer Tumor Profiling Market Trends And Strategies

4. Cancer Tumor Profiling Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cancer Tumor Profiling Market Size and Growth

  • 5.1. Global Cancer Tumor Profiling Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cancer Tumor Profiling Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cancer Tumor Profiling Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cancer Tumor Profiling Market Segmentation

  • 6.1. Global Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma
  • Ovarian Cancer
  • Stomach Cancer
  • Pancreatic Cancer
  • Thyroid Cancer
  • Other Cancer Types
  • 6.2. Global Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In Situ Hybridization (ISH)
  • Microarray
  • Other Technologies
  • 6.3. Global Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Research Applications

7. Cancer Tumor Profiling Market Regional And Country Analysis

  • 7.1. Global Cancer Tumor Profiling Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cancer Tumor Profiling Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cancer Tumor Profiling Market

  • 8.1. Asia-Pacific Cancer Tumor Profiling Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cancer Tumor Profiling Market

  • 9.1. China Cancer Tumor Profiling Market Overview
  • 9.2. China Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cancer Tumor Profiling Market

  • 10.1. India Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cancer Tumor Profiling Market

  • 11.1. Japan Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cancer Tumor Profiling Market

  • 12.1. Australia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cancer Tumor Profiling Market

  • 13.1. Indonesia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cancer Tumor Profiling Market

  • 14.1. South Korea Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cancer Tumor Profiling Market

  • 15.1. Western Europe Cancer Tumor Profiling Market Overview
  • 15.2. Western Europe Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cancer Tumor Profiling Market

  • 16.1. UK Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cancer Tumor Profiling Market

  • 17.1. Germany Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cancer Tumor Profiling Market

  • 18.5. France Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cancer Tumor Profiling Market

  • 19.9. Italy Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cancer Tumor Profiling Market

  • 20.13. Spain Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cancer Tumor Profiling Market

  • 21.1. Eastern Europe Cancer Tumor Profiling Market Overview
  • 21.2. Eastern Europe Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cancer Tumor Profiling Market

  • 22.1. Russia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cancer Tumor Profiling Market

  • 23.1. North America Cancer Tumor Profiling Market Overview
  • 23.2. North America Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cancer Tumor Profiling Market

  • 24.1. USA Cancer Tumor Profiling Market Overview
  • 24.2. USA Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cancer Tumor Profiling Market

  • 25.1. Canada Cancer Tumor Profiling Market Overview
  • 25.2. Canada Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cancer Tumor Profiling Market

  • 26.1. South America Cancer Tumor Profiling Market Overview
  • 26.2. South America Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cancer Tumor Profiling Market

  • 27.1. Brazil Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cancer Tumor Profiling Market

  • 28.1. Middle East Cancer Tumor Profiling Market Overview
  • 28.2. Middle East Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cancer Tumor Profiling Market

  • 29.1. Africa Cancer Tumor Profiling Market Overview
  • 29.2. Africa Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cancer Tumor Profiling Market Competitive Landscape And Company Profiles

  • 30.1. Cancer Tumor Profiling Market Competitive Landscape
  • 30.2. Cancer Tumor Profiling Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Caris Life Sciences
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Illumina Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Qiagen
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Cancer Tumor Profiling Market Competitive Benchmarking

32. Global Cancer Tumor Profiling Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Cancer Tumor Profiling Market

34. Cancer Tumor Profiling Market Future Outlook and Potential Analysis

  • 34.1 Cancer Tumor Profiling Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Cancer Tumor Profiling Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Cancer Tumor Profiling Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer